The Effect of Consuming on Body Composition and Blood Biochemistry Index

N/ACompletedNCT04501601

TCI Co., Ltd.25 enrolled

Overview

To assess the effect of consuming on body composition and blood biochemistry index

Study Type

INTERVENTIONAL

Allocation

Purpose

OTHER

Masking

NONE

Enrollment

Conditions

Gut Microbiota

Interventions

Fruit and vegetable solid drinkDIETARY_SUPPLEMENT

weight loss program supplement

Eligibility

Sex: ALLMin age: 20 YearsMax age: 60 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * Male or female aged between 20 and 60 years old * Body mass index (BMI) ≥ 24 (kg/m\^2) or body fat mass: male \> 25%, female \> 30% * Prohibitions on other nutritional supplements (probiotics and prebiotics) before two weeks of the study * Abidance by the similar diet and exercise habits over the study. Exclusion Criteria: * Pregnant or breastfeeding woman * Menopausal woman * Diabetes mellitus * Implementation in weight loss programs before a half year of this study * Metabolic disorders * Kidney diseases * Liver diseases * Cardiovascular diseases * Nervous system diseases * Gastrointestinal diseases * Heavy drinking or constant drug use.

Locations (1)

National Pingtung University of Science and Technology

Pingtung City, Neipu Township, Taiwan

Outcomes

Primary Outcomes

The change of body fat mass

The body fat mass (kg) was assessed by InBody770.

Time frame: Change from Baseline body fat mass at 2 months

The change of Triglyceride

Venous blood was sampled to measure concentrations of Triglyceride

Time frame: Change from Baseline triglyceride at 2 months

The change of Total cholesterol

Venous blood was sampled to measure concentrations of Total cholestrol

Time frame: Change from Baseline total cholesterol at 2 months

The change of HDL-cholesterol

Venous blood was sampled to measure concentrations of HDL-cholestrol

Time frame: Change from Baseline HDL-cholesterol at 2 months

The change of LDL-cholesterol

Venous blood was sampled to measure concentrations of LDL-cholestrol

Time frame: Change from Baseline LDL-cholesterol at 2 months

Fecal microbiome analysis

Firmicutes, Bacteroidetes, Lactobucillius, and A. muciniphila were quantified by quantitative PCR.

Time frame: Change from Baseline Fecal microbiome at 2 months

The change of body mass index (BMI)

BMI is a measurement of a person's leanness or corpulence based on their height and weight, and is intended to quantify tissue mass.The body mass index (BMI, kg/m\^2) and body mass (kg) were assessed by InBody770.

Time frame: Change from Baseline body mass index at 2 months

The change of body fat percentage

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.

Secondary Outcomes

The change of fasting glycemia

Venous blood was sampled to measure concentrations of fasting glycemia

Time frame: Change from Baseline fasting glycemia at 2 months

The change of aspartate aminotransferase

Venous blood was sampled to measure concentrations of aspartate aminotransferase

Time frame: Change from Baseline aspartate aminotransferase at 2 months

The change of alanine aminotransferase

Venous blood was sampled to measure concentrations of alanine aminotransferase

Time frame: Change from Baseline alanine aminotransferase at 2 months

The change of albumin

Venous blood was sampled to measure concentrations of albumin

Time frame: Change from Baseline albumin at 2 months

The change of creatinine

Venous blood was sampled to measure concentrations of creatine

Time frame: Change from Baseline creatinine at 2 months

The change of uric acid

Venous blood was sampled to measure concentrations of uric acid

Time frame: Change from Baseline uric acid at 2 months

The change of white blood cell

Venous blood was sampled to measure concentrations of white blood cell

Time frame: Change from Baseline white blood cell at 2 months